A new wave of metabolic disease drugs beyond GLP-1 agonists is emerging to address the unmet needs of patients.

Ruminant BioTech has a product with "high mitigation potential and a long duration that’s easy to adopt it at the farm" says ...

Heart disease is the leading cause of death in the United States, and about every 40 seconds, someone has a heart attack.

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...

Parenting a child with Type 1 diabetes involves teaching them responsibility and self-advocacy to manage their condition.

That invisible burden affects the whole family. Parents carry worry that never really goes away. Siblings sometimes feel ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

EMERYVILLE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such as the ThecaFlex ...

I didn’t sleep for weeks. Every beep, every slight change in his numbers, every outing with friends felt like a risk I couldn’t control. Unlike the scrapes and skinned knees of early childhood, this ...

Elephant families are matriarchal, inclusive and caring. But when environmental scarcity hits, everything changes ...